242 related articles for article (PubMed ID: 1313356)
1. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients.
Klijn JG; Berns PM; Schmitz PI; Foekens JA
Endocr Rev; 1992 Feb; 13(1):3-17. PubMed ID: 1313356
[TBL] [Abstract][Full Text] [Related]
2. EGF-R expression in ductal breast cancer: proliferation and prognostic implications.
Bucci B; D'Agnano I; Botti C; Mottolese M; Carico E; Zupi G; Vecchione A
Anticancer Res; 1997; 17(1B):769-74. PubMed ID: 9066618
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer.
Foekens JA; Portengen H; van Putten WL; Trapman AM; Reubi JC; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Dec; 49(24 Pt 1):7002-9. PubMed ID: 2555057
[TBL] [Abstract][Full Text] [Related]
4. Correlation of the EGF-receptor with cell kinetic and classical prognostic factors in breast cancer.
Oehler MK; Rehn M; Kristen P; Sütterlin M; Caffier H
Anticancer Res; 1997; 17(4B):3137-40. PubMed ID: 9329620
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of epidermal growth factor receptor lacks prognostic significance for breast carcinoma.
Göhring UJ; Ahr A; Scharl A; Weisner V; Neuhaus W; Crombach G; Holt JA
J Soc Gynecol Investig; 1995; 2(4):653-9. PubMed ID: 9420872
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the receptor for epidermal growth factor in human mammary carcinomas.
Macias A; Azavedo E; Hägerström T; Klintenberg C; Pérez R; Skoog L
Anticancer Res; 1987; 7(3 Pt B):459-64. PubMed ID: 3631906
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study.
Klijn JG; Look MP; Portengen H; Alexieva-Figusch J; van Putten WL; Foekens JA
Breast Cancer Res Treat; 1994 Jan; 29(1):73-83. PubMed ID: 8018964
[TBL] [Abstract][Full Text] [Related]
8. Relationships between epidermal growth factor receptor (EGF-R) and other predictors of prognosis in breast carcinomas. An immunohistochemical study.
Martinazzi M; Crivelli F; Zampatti C; Martinazzi S
Pathologica; 1993; 85(1100):637-44. PubMed ID: 8170712
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
[TBL] [Abstract][Full Text] [Related]
10. Combined overexpression of c-erbB-2 protein and epidermal growth factor receptor (EGF-R) could be predictive of early and long-term outcome in human breast cancer: a pilot study.
Delarue JC; Terrier P; Terrier-Lacombe MJ; Mouriesse H; Gotteland M; May-Levin F
Bull Cancer; 1994 Dec; 81(12):1067-77. PubMed ID: 7742595
[TBL] [Abstract][Full Text] [Related]
11. Expression of epidermal growth factor receptor (EGFR) in breast cancer as related to clinical, prognostic and cytometric factors.
Pirinen R; Lipponen P; Syrjänen K
Anticancer Res; 1995; 15(6B):2835-40. PubMed ID: 8669874
[TBL] [Abstract][Full Text] [Related]
12. [Epidermal growth factor receptor in human breast cancer: correlation with steroid receptors, tumor stage, grading and menopausal status].
Speiser P; Sliutz G; Zeillinger R; Czerwenka K; Jakesz R; Knogler W; Kury F; Reiner A; Sevelda P; Schneeberger C
Geburtshilfe Frauenheilkd; 1992 Jun; 52(6):355-9. PubMed ID: 1634099
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of the prognostic significance of epidermal growth factor receptor in primary breast cancer.
Seshadri R; McLeay WR; Horsfall DJ; McCaul K
Int J Cancer; 1996 Feb; 69(1):23-7. PubMed ID: 8600054
[TBL] [Abstract][Full Text] [Related]
15. Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease.
Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Branković-Magić M; Kanjer K; Gavrilović D; Mitrović L; Borojević N; Vukotić D; Spuzić I
J Exp Clin Cancer Res; 1999 Sep; 18(3):347-55. PubMed ID: 10606181
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of TGF-alpha, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression.
Spaventi R; Kamenjicki E; Pecina N; Grazio S; Grazio S; Pavelic J; Kusic B; Cvrtila D; Danilovic Z; Spaventi S
In Vivo; 1994; 8(2):183-9. PubMed ID: 7919121
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
[TBL] [Abstract][Full Text] [Related]
18. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I
Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476
[TBL] [Abstract][Full Text] [Related]
19. Relationship of the epidermal growth factor-receptor to the growth fraction (Ki-67 antibody) and the flow cytometric S-phase as cell kinetics parameters, in human mammary carcinomas.
Gasparini G; Reitano M; Bevilacqua P; Meli S; Pozza F; Santini G
Anticancer Res; 1991; 11(4):1597-603. PubMed ID: 1746917
[TBL] [Abstract][Full Text] [Related]
20. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]